Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antibody Drug Conjugate
1.2 Key Market Segments
1.2.1 Antibody Drug Conjugate Segment by Type
1.2.2 Antibody Drug Conjugate Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antibody Drug Conjugate Market Overview
2.1 Global Market Overview
2.1.1 Global Antibody Drug Conjugate Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antibody Drug Conjugate Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antibody Drug Conjugate Market Competitive Landscape
3.1 Global Antibody Drug Conjugate Sales by Manufacturers (2019-2024)
3.2 Global Antibody Drug Conjugate Revenue Market Share by Manufacturers (2019-2024)
3.3 Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antibody Drug Conjugate Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antibody Drug Conjugate Sales Sites, Area Served, Product Type
3.6 Antibody Drug Conjugate Market Competitive Situation and Trends
3.6.1 Antibody Drug Conjugate Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antibody Drug Conjugate Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antibody Drug Conjugate Industry Chain Analysis
4.1 Antibody Drug Conjugate Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antibody Drug Conjugate Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antibody Drug Conjugate Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antibody Drug Conjugate Sales Market Share by Type (2019-2024)
6.3 Global Antibody Drug Conjugate Market Size Market Share by Type (2019-2024)
6.4 Global Antibody Drug Conjugate Price by Type (2019-2024)
7 Antibody Drug Conjugate Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antibody Drug Conjugate Market Sales by Application (2019-2024)
7.3 Global Antibody Drug Conjugate Market Size (M USD) by Application (2019-2024)
7.4 Global Antibody Drug Conjugate Sales Growth Rate by Application (2019-2024)
8 Antibody Drug Conjugate Market Segmentation by Region
8.1 Global Antibody Drug Conjugate Sales by Region
8.1.1 Global Antibody Drug Conjugate Sales by Region
8.1.2 Global Antibody Drug Conjugate Sales Market Share by Region
8.2 North America
8.2.1 North America Antibody Drug Conjugate Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antibody Drug Conjugate Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antibody Drug Conjugate Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antibody Drug Conjugate Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antibody Drug Conjugate Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Seattle Genetics/Takeda
9.1.1 Seattle Genetics/Takeda Antibody Drug Conjugate Basic Information
9.1.2 Seattle Genetics/Takeda Antibody Drug Conjugate Product Overview
9.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Product Market Performance
9.1.4 Seattle Genetics/Takeda Business Overview
9.1.5 Seattle Genetics/Takeda Antibody Drug Conjugate SWOT Analysis
9.1.6 Seattle Genetics/Takeda Recent Developments
9.2 Roche
9.2.1 Roche Antibody Drug Conjugate Basic Information
9.2.2 Roche Antibody Drug Conjugate Product Overview
9.2.3 Roche Antibody Drug Conjugate Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Antibody Drug Conjugate SWOT Analysis
9.2.6 Roche Recent Developments
9.3 ImmunoGen
9.3.1 ImmunoGen Antibody Drug Conjugate Basic Information
9.3.2 ImmunoGen Antibody Drug Conjugate Product Overview
9.3.3 ImmunoGen Antibody Drug Conjugate Product Market Performance
9.3.4 ImmunoGen Antibody Drug Conjugate SWOT Analysis
9.3.5 ImmunoGen Business Overview
9.3.6 ImmunoGen Recent Developments
9.4 Immunomedics
9.4.1 Immunomedics Antibody Drug Conjugate Basic Information
9.4.2 Immunomedics Antibody Drug Conjugate Product Overview
9.4.3 Immunomedics Antibody Drug Conjugate Product Market Performance
9.4.4 Immunomedics Business Overview
9.4.5 Immunomedics Recent Developments
9.5 Pfizer
9.5.1 Pfizer Antibody Drug Conjugate Basic Information
9.5.2 Pfizer Antibody Drug Conjugate Product Overview
9.5.3 Pfizer Antibody Drug Conjugate Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Celldex Therapeutics
9.6.1 Celldex Therapeutics Antibody Drug Conjugate Basic Information
9.6.2 Celldex Therapeutics Antibody Drug Conjugate Product Overview
9.6.3 Celldex Therapeutics Antibody Drug Conjugate Product Market Performance
9.6.4 Celldex Therapeutics Business Overview
9.6.5 Celldex Therapeutics Recent Developments
9.7 Millennium Pharmaceuticals
9.7.1 Millennium Pharmaceuticals Antibody Drug Conjugate Basic Information
9.7.2 Millennium Pharmaceuticals Antibody Drug Conjugate Product Overview
9.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Product Market Performance
9.7.4 Millennium Pharmaceuticals Business Overview
9.7.5 Millennium Pharmaceuticals Recent Developments
9.8 Bayer HealthCare
9.8.1 Bayer HealthCare Antibody Drug Conjugate Basic Information
9.8.2 Bayer HealthCare Antibody Drug Conjugate Product Overview
9.8.3 Bayer HealthCare Antibody Drug Conjugate Product Market Performance
9.8.4 Bayer HealthCare Business Overview
9.8.5 Bayer HealthCare Recent Developments
9.9 Mersana Therapeutics
9.9.1 Mersana Therapeutics Antibody Drug Conjugate Basic Information
9.9.2 Mersana Therapeutics Antibody Drug Conjugate Product Overview
9.9.3 Mersana Therapeutics Antibody Drug Conjugate Product Market Performance
9.9.4 Mersana Therapeutics Business Overview
9.9.5 Mersana Therapeutics Recent Developments
9.10 Heidelberg Pharma
9.10.1 Heidelberg Pharma Antibody Drug Conjugate Basic Information
9.10.2 Heidelberg Pharma Antibody Drug Conjugate Product Overview
9.10.3 Heidelberg Pharma Antibody Drug Conjugate Product Market Performance
9.10.4 Heidelberg Pharma Business Overview
9.10.5 Heidelberg Pharma Recent Developments
9.11 Oxford BioTherapeutics
9.11.1 Oxford BioTherapeutics Antibody Drug Conjugate Basic Information
9.11.2 Oxford BioTherapeutics Antibody Drug Conjugate Product Overview
9.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Product Market Performance
9.11.4 Oxford BioTherapeutics Business Overview
9.11.5 Oxford BioTherapeutics Recent Developments
9.12 Takeda Pharmaceutical Company Limited
9.12.1 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Basic Information
9.12.2 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Overview
9.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Market Performance
9.12.4 Takeda Pharmaceutical Company Limited Business Overview
9.12.5 Takeda Pharmaceutical Company Limited Recent Developments
10 Antibody Drug Conjugate Market Forecast by Region
10.1 Global Antibody Drug Conjugate Market Size Forecast
10.2 Global Antibody Drug Conjugate Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antibody Drug Conjugate Market Size Forecast by Country
10.2.3 Asia Pacific Antibody Drug Conjugate Market Size Forecast by Region
10.2.4 South America Antibody Drug Conjugate Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antibody Drug Conjugate by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Antibody Drug Conjugate Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antibody Drug Conjugate by Type (2025-2030)
11.1.2 Global Antibody Drug Conjugate Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antibody Drug Conjugate by Type (2025-2030)
11.2 Global Antibody Drug Conjugate Market Forecast by Application (2025-2030)
11.2.1 Global Antibody Drug Conjugate Sales (Kilotons) Forecast by Application
11.2.2 Global Antibody Drug Conjugate Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
